CRISM developed the first Canadian guideline for managing opioid use disorders. The guideline lays out the optimal strategies for the treatment of opioid addiction and recommends opioid agonist treatment with buprenorphine-naloxone as the preferred first-line treatment.
Recommendations at a glance (English)
Recommendations at a glance (French)
A synopsis of the Guideline was published in the Canadian Medical Association Journal:
Did you know? Buprenorphine/Naloxone
Did you know? Slow-release oral morphine
Withdrawal Management Safety Bulletin